Quick Takeaways: Why It Matters? By bringing real-time, cellular-level microscopic imaging into everyday veterinary workflows, without lab delays, InSpecta gives specialist, general, and mobile practices a new in‑house diagnostic capability that can speed decision-making and create billabl...
Featured Article Cover Story Regulatory Updates Launch Product Launch PetMeds Receives New Acquisition Proposal Corporate transaction PetMed Express has received an unsolicited, non-binding proposal from SilverCape Investments to acquire all outstanding shares for $3.00 per share in cash. ...
Quick Takeaways: Why It Matters? Marley Health’s launch pushes veterinary care toward continuous, data-driven monitoring by combining a smart collar with vet and owner tools that track clinically meaningful biomarkers like gait, posture, resting heart rate, and respiratory rate between vis...
Featured Article Cover Story Regulatory Updates Research Updates Product Launch Retail expansion Dechra Opens Global Headquarters in Boston Corporate update Dechra has opened its new global headquarters in Boston, strengthening its innovation footprint while supporting community programs t...
Quick Takeaways: Why It Matters? Full FDA approval for Laverdia transforms it from a conditionally approved option into the first fully approved oral, at‑home standard therapy for canine lymphoma, which should significantly boost veterinarian confidence and utilization via Dechra’s nationa...
Quick Takeaways: Why It Matters? Jaguar’s NADA submission is a meaningful de-risking step for Canalevia-CA1, because full FDA approval would likely expand its commercial credibility beyond conditional use and make it easier to gain adoption in veterinary onc...
Quick Takeaways: Why It Matters? CompanAIn’s Veterinary Portal broadens its AI pet-wellness platform from owner-facing tools into a shared clinical workflow, which could make the product stickier for clinics and more valuable for longitudinal care. By giving vets ...
Featured Article Cover Story Research Updates Regulatory Approval Product Launches Elanco Launches $25 Million Venture Fund Innovation platform Elanco Animal Health plans to launch Elanco Ventures, a $25 million corporate venture platform to back early-stage animal health innovation. Key h...
The US FDA’s 2025 animal health approvals highlight a transformative year for veterinary medicine, with major advances spanning companion animal therapeutics, livestock productivity, poultry health, parasitic disease management, diagnostics, oncology, and genetic innovation. The latest wav...
Quick Takeaways: Why It Matters? Elanco Ventures adds a structured, early-stage venture arm to Elanco’s strategy, giving the company a dedicated channel to access and co-develop emerging animal health technologies before they become mature competitors or acquisition targets. The ...
